Fisher & Paykel Healthcare's stock surged 8.54% intraday on Tuesday, significantly outperforming the broader market.
The sharp rise followed the company's release of its fiscal 2026 earnings report, which showed underlying earnings per share of NZ$0.793, a substantial increase from NZ$0.639 a year earlier, indicating strong financial performance and growth.
The health technology sector was a notable gainer on the exchange during the session, with Fisher & Paykel Healthcare leading the advance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.